$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Magnetic resonance imaging (MRI) has substantially enhanced our ability to examine the brain anatomy and functions in neurodegenerative diseases1,2,3. T1-weighted structural MRI is one of most widely adopted imaging tools in routine clinical practice to assess the brain anatomy and related pathology. Quantitative analysis of the high-resolution T1-weighted images provides useful markers to measure anatomical changes during brain degeneration. In particular, segmentation based quantification approaches effectively reduces the image dimensionality from voxel level (on the order of (106)) to anatomical structural level ((102)) for high-throughput neuroinformatics4,5. Automated brain segmentation can be achieved using atlas-based methods6,7,8,9 that map the pre-defined anatomical labels from an atlas onto the patient images. Among the atlas-based methods, multi-atlas algorithms10,11,12,13,14 have yielded superior segmentation accuracy and robustness. Our group has developed a fully automated T1 multi-atlas segmentation pipeline, with advanced diffeomorphic image registration algorithms15, multi-atlas fusion methods16,17, and rich multi-atlas libraries18. The pipeline has been distributed on a cloud-computing platform, MRICloud19, since 2015, and it has been used to study neurodegenerative diseases, such as Alzheimer's disease (AD)20,21, Primary Progressive Aphasia22, and Huntington's Disease23.
Once the high-resolution images are segmented into brain structures, regional features, such as volumes, can be used to establish mathematical models to characterize the neuroanatomical changes. A change-point analysis method was recently established by our group to analyze the temporal order, in which statistically significant brain morphometric changes occur, based on longitudinal and/or cross-sectional MRI data. This statistical model was first developed to quantify shape-based diffeomorphometry over age in AD patients21,24; and it was later adapted to investigate brain structural changes in Huntington's disease (HD), as well as to describe brain developmental changes in neonatal brains25. In HD patients, the change-point was defined in with respect to the CAG-age product (CAP) score, as an indicator of the extent of exposure to the CAG expansion in HTT 26. It is well-known that striatal atrophy is one of the earliest markers in HD, followed by the globus pallidus27. Yet, the changes in striatum in relation to other gray and white matter structures across the brain remains unclear. Such relation is crucial for us to understand the disease progression. Change-point analysis of volumetric changes in all brain structures will likely provide systematic information of brain atrophy in premanifest phase of HD.
Here we demonstrate the procedures to perform whole-brain segmentation using MRICloud (www.mricloud.org), and steps to perform change-point analysis of volumetric data in premanifest HD subjects. The MRI data were collected from a large population multicenter PREDICT-HD study28,29 with approximately 400 controls and premanifest HD subjects. The combination of atlas-based segmentation and change-point analysis brings unique information about the spatiotemporal order of the brain structural changes and the disease progression pattern across the brain. The techniques are potentially applicable to a range of neurodegenerative diseases with various biomarkers to map the brain degeneration.